Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.91% | $201.58M | €361.36B | 38.64% | 76 Outperform | |
| Roche Holding AG | 1.88% | $129.88M | CHF257.44B | 37.41% | 73 Outperform | |
| AstraZeneca | 1.87% | $129.58M | £209.51B | 28.65% | 80 Outperform | |
| HSBC Holdings | 1.74% | $120.16M | HK$1.97T | 46.18% | 80 Outperform | |
| SAP SE | 1.73% | $119.79M | €246.20B | -12.66% | 66 Neutral | |
| Nestlé SA | 1.69% | $116.90M | CHF196.65B | 15.97% | 71 Outperform | |
| Novartis AG | 1.68% | $116.58M | CHF200.64B | 20.35% | 80 Outperform | |
| Siemens | 1.44% | $99.46M | €181.39B | 21.30% | 74 Outperform | |
| Shell (UK) | 1.41% | $97.79M | £154.81B | 8.06% | 73 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.24% | $85.56M | €307.60B | -3.60% | 78 Outperform |